# EMPOWER Early Feasibility Study: Non-invasive BCI to Control a Wheelchair for People With Paralysis

> **NCT06169696** · NA · UNKNOWN · sponsor: **Synaptrix Labs Inc.** · enrollment: 6 (estimated)

## Conditions studied

- Neurologic Disorder
- Paralysis
- Paralysis; Stroke
- Amyotrophic Lateral Sclerosis
- Spinal Cord Injuries
- Cervical Spinal Cord Injury
- Tetraplegic; Paralysis
- Quadriplegia/Tetraplegia

## Interventions

- **DEVICE:** Intervention/Treatment

## Key facts

- **NCT ID:** NCT06169696
- **Lead sponsor:** Synaptrix Labs Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-11
- **Primary completion:** 2025-01
- **Final completion:** 2025-01
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06169696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06169696, "EMPOWER Early Feasibility Study: Non-invasive BCI to Control a Wheelchair for People With Paralysis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06169696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*